Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News

November 13, 2009 – A new study, published in the Nov. 17, 2009 issue of the Journal of the American College of ...

Home November 13, 2009
Home
News

November 2, 2009 — Cardiac complications around the time of noncardiac surgery are relatively common and can be ...

Home November 02, 2009
Home
News

October 29. 2009 – Results of the SLIM Study ("Slo-Niacin and Atorvastatin Treatment of Lipoproteins and ...

Home October 29, 2009
Home
News

October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete ...

Home October 21, 2009
Home
Technology

October 19, 2009 – Boehringer Ingelheim Pharmaceuticals Inc. said today the FDA approved the supplemental new ...

Home October 19, 2009
Home
Technology

October 16, 2009 – AstraZeneca yesterday said the U.S. Food and Drug Administration cleared CRESTOR (rosuvastatin ...

Home October 16, 2009
Home
Technology

October 12, 2009 – Daiichi Sankyo Inc. (DSI) last week said the U.S. Food and Drug Administration (FDA) approved ...

Home October 12, 2009
Home
News

October 9, 2009 – CardioPharma is beginning the final funding phase before submitting an FDA new drug application ...

Home October 09, 2009
Home
News

October 8, 2009 – In a recent survey of more than 2,000 U.S. physicians conducted by Epocrates Inc., cardiologists ...

Home October 08, 2009
Home
News

October 6, 2009 – The Harvard Clinical Research Institute (HCRI) said last week the first patients are enrolled ...

Home October 06, 2009
Home
News

October 5, 2009 – A reduction in stroke was observed in patients with atrial fibrillation (AF) who received ...

Home October 05, 2009
Home
News

October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A ...

Home October 05, 2009
Home
News

September 28, 2009 – New data from the phase III PLATO study showed that ticagrelor (BRILINTA) provided 16 ...

Home September 29, 2009
Home
News

September 28, 2009 – Sanofi-aventis announced last week the Committee for Medicinal Products for Human Use (CHMP) ...

Home September 29, 2009
Home
News

September 18, 2009 – Patients’ response to anti-platelet therapy after percutaneous coronary intervention (PCI) ...

Home September 18, 2009
Home
Subscribe Now